Cory Kasimov
Stock Analyst at Evercore ISI Group
(0)
# 4316
Out of 5,218 analysts
89
Total ratings
41.03%
Success rate
-8.61%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Edgewise Therapeutic... | Initiates Coverage On: Outperform | 45 | 27.61 | 62.98% | 1 | Nov 22, 2024 | |
SpringWorks Therapeu... | Initiates Coverage On: Outperform | 60 | 38.38 | 56.33% | 1 | Nov 20, 2024 | |
BioNTech | Upgrades: Outperform | 110 125 | 120.2 | 3.99% | 4 | Nov 19, 2024 | |
Biomarin Pharmaceuti... | Maintains: Outperform | 115 105 | 66.03 | 59.02% | 10 | Oct 30, 2024 | |
Regeneron Pharmaceut... | Maintains: Outperform | 1250 1175 | 730.7 | 60.8% | 5 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 50 45 | 27.5 | 63.64% | 2 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: In-Line | 120 120 | 41.83 | 186.88% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 85 | 83.86 | 1.36% | 1 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 175 | 126.68 | 38.14% | 1 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 84 88 | 45.88 | 91.8% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 260 250 | n/a | n/a | 2 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 50 | n/a | n/a | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 324 276 | 150.04 | 83.95% | 3 | Dec 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 35 | 1.89 | 1751.85% | 1 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 1520 780 | 6.36 | 12164.15% | 3 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 225 232 | 270.45 | -14.22% | 5 | Jul 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 4 | May 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | May 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 168 163 | n/a | n/a | 2 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 25 21 | 30.46 | -31.06% | 2 | Feb 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 4 | Nov 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 83 23 | 2.85 | 707.02% | 6 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 71 16 | n/a | n/a | 8 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 60 63 | n/a | n/a | 5 | May 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Overweight | 110 | n/a | n/a | 2 | Mar 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 4 | Feb 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 15 10 | 0.82 | 1119.51% | 1 | Feb 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 310 250 | 12.97 | 1827.53% | 1 | Feb 14, 2018 |